MPLN Similar Chart Price Prediction
The price of MPLN is predicted to go up -0.32%, based on the high correlation periods with EFT. The similarity of these two price pattern on the periods is 99.23%.
MPLN
EFT
Down: -0.32%Similarity: 99.23%
MPLN Revenue Forecast
MPLN EPS Forecast
MPLN FAQs
What is bull’s view on MPLN?
What is bear's view on MPLN?
What is MPLN revenue forecast for next quarter？
MPLN Analyst's Forecast
Daniel Grosslight
Citigroup
Hold
2025-01-10
Price Target
$10 → $13
Downside
-1.81%
Citi analyst Daniel Grosslight raised the firm's price target on MultiPlan to $12.50 from $10 and keeps a Neutral rating on the shares as part of a 2025 outcook for the health technology and distribution group. The firm says that while 2024 was another difficult year for health tech stocks, rather than being driven by deteriorating fundamentals, much of the selloff was due to continued multiple compression, which signals "we have likely reached a valuation floor." Looking ahead to 2025, Citi is "cautiously optimistic" on the health tech space, saying there seems to be a bit of a post-election risk bid, acquisition activity has accelerated, and expectations have been sufficiently reset. Citi names Health Catalyst (HCAT) its top health tech pick and Cencora (COR) its top distribution pick.
Daniel Grosslight
Citigroup
Hold
2024-09-23
Price Target
$17 → $10
Upside
+35.32%
